US Broker Ratings

Celldex Therapeutics (CLDX) Stock Analysis: Exploring a Potential 165.96% Upside in Biotech

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a dynamic player in the biotechnology sector, has captured the attention of investors with its impressive growth potential and innovative approach..

Surgery Partners, Inc. (SGRY) Stock Analysis: Uncovering a 39.77% Potential Upside Amid Healthcare Growth

Surgery Partners, Inc. (NASDAQ: SGRY), a prominent player in the healthcare sector, has been catching the eye of investors with its robust network of surgical facilities..

Select Medical Holdings Corp (SEM) Stock Analysis: A 44.88% Potential Upside Worth Watching

Select Medical Holdings Corporation (NYSE: SEM) is a key player in the healthcare sector, operating a diverse network of critical illness recovery hospitals, rehabilitation hospitals, and..

National HealthCare Corporation (NHC) Stock Analysis: A Deeper Look into Its 25.7% Revenue Growth and Dividend Yield

National HealthCare Corporation (NYSE: NHC), a key player in the healthcare sector, offers a diverse range of services focusing on skilled nursing facilities, assisted living, homecare,..

Ardent Health, Inc. (ARDT) Stock Analysis: Potential Upside of Nearly 90% Awaits Investors

Ardent Health, Inc. (ARDT), a key player in the healthcare sector, is drawing investor attention with a compelling potential upside of 89.83%. As a company operating..

Warby Parker Inc. (WRBY) Stock Analysis: Evaluating a Healthcare Retail Innovator with 11.9% Revenue Growth

Warby Parker Inc. (NYSE: WRBY) stands out as an intriguing player in the healthcare sector, nestled within the medical instruments and supplies industry. Known for its..

BGM Group Ltd. (BGM) Stock Analysis: Navigating Challenges in the Healthcare Sector

BGM Group Ltd. (BGM), a prominent player in China’s healthcare sector, is currently navigating a challenging financial landscape. With a market capitalization of $2.01 billion, the..

Novavax, Inc. (NVAX) Stock Analysis: Exploring a Potential 82.50% Upside in the Biotech Sector

Novavax, Inc. (NVAX), a prominent player in the biotechnology industry, has captured investor attention with its innovative vaccine technologies and significant potential upside. Headquartered in Gaithersburg,..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Exploring a Potential Upside of 143.95% in the Biotech Arena

Apogee Therapeutics, Inc. (NASDAQ: APGE), a burgeoning entity in the biotechnology sector, has caught the attention of investors with its promising prospects in the treatment of..

Adaptive Biotechnologies (ADPT) Stock Analysis: A Promising Biotech Play with 14.45% Upside Potential

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a key player in the biotechnology sector, is attracting attention from investors with its innovative approach to diagnosing and treating diseases..

Omnicell, Inc. (OMCL) Stock Analysis: A 51% Upside Potential in Healthcare Tech

Omnicell, Inc. (NASDAQ: OMCL) stands as a noteworthy player in the healthcare technology sector, specializing in medication management solutions and adherence tools. With a market capitalization..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 39.68% Potential Upside

Investors with a focus on the healthcare sector may find Pacira BioSciences, Inc. (NASDAQ: PCRX) an intriguing prospect given its potential upside of nearly 40%. With..

HUTCHMED (China) Limited (HCM) Stock Analysis: Discovering a 35% Upside Potential in the Healthcare Sector

HUTCHMED (China) Limited (HCM), a prominent player in the healthcare sector, is capturing investor attention with its promising 35.03% potential upside, according to current analyst targets...

UFP Technologies (UFPT) Stock Analysis: 27% Potential Upside in the Medical Device Sector

UFP Technologies, Inc. (NASDAQ: UFPT) stands out as a compelling player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of..

Neogen Corporation (NEOG) Stock Analysis: Exploring a 38% Potential Upside in the Healthcare Sector

Neogen Corporation (NASDAQ: NEOG) stands at the intersection of innovation and essential services in the healthcare sector. As a key player in the diagnostics and research..

CG Oncology, Inc. (CGON) Growth Potential: Exploring a 119.64% Upside Amidst Clinical Trials Success

CG Oncology, Inc. (CGON) is a biopharmaceutical company that has garnered significant attention in the healthcare sector, particularly in the biotechnology industry. Headquartered in Irvine, California,..

PACS Group, Inc. (PACS) Stock Analysis: Exploring a 159% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, PACS Group, Inc. (PACS) presents an intriguing proposition. Operating in the niche of skilled nursing and assisted living..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Exploring the 22.37% Potential Upside for Investors

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a key player in the healthcare sector, is capturing the attention of investors with its significant growth potential. With a market..

Azenta, Inc. (AZTA) Stock Analysis: Navigating Growth in the Healthcare Sector

Azenta, Inc. (NASDAQ: AZTA), an influential player in the healthcare sector, specializes in providing cutting-edge biological and chemical compound sample exploration and management solutions. With its..

Twist Bioscience Corporation (TWST) Stock Analysis: Unlocking a 32% Potential Upside in Synthetic DNA Innovation

Twist Bioscience Corporation (NASDAQ: TWST) is making waves in the healthcare sector with its innovative approach to synthetic DNA products. Headquartered in South San Francisco, California,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds